Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Environment and bladder cancer: molecular analysis by interaction networks.
Data-mining analysis identified genes/proteins and their mutations.
»
03/16/17
Validity of self-reported breast cancer characteristics in a nationwide cohort of women with a family history of breast cancer
Self-reported in situ breast cancer had a lower positive predictive value (PPV).
»
10/23/17
Exercise and cancer-related fatigue in adults: a systematic review of previous systematic reviews with meta-analyses
Exercise does not appear to increase cancer-related fatigue in adults.
»
10/23/17
Sporadic
PCDH18
somatic mutations in EpCAM-positive hepatocellular carcinoma
PCDH18 functionally suppressed in subset of EpCAM-positive HCCs.
»
10/23/17
The Use of MRI to Predict Oncological Control among Candidates for Focal Ablation of Prostate Cancer.
Active surveillance of the untreated prostate is mandatory.
»
08/15/17
Smoking cessation and survival in lung, upper aero-digestive tract and bladder cancer: cohort study.
In lung cancer patients that quit, all-cause mortality was significantly lower.
»
01/23/17
miR-6883 family miRNAs target CDK4/6 to induce G1 phase cell cycle arrest in colon cancer cells.
Candidate miRNA-based theranostic strategy to improve CRC management.
»
10/03/17
Anticancer Effects of Colchicine on Hypopharyngeal Cancer.
Colchicine can suppress cell invasion, migration, and adhesion.
»
04/12/17
Dual roles of tumour cells-derived matrix metalloproteinase 2 on brain tumour growth and invasion.
Suppression of MMP2 expression prolonged the survival of tumour-bearing mice.
»
02/24/17
Genomic predictors of chemotherapy efficacy in advanced or recurrent gastric cancer in the GC0301/TOP002 phase III clinical trial.
Mesenchymal subtype showed a trend for treatment interaction with IRI-S for efficacy.
»
08/14/17
< Prev
Next >